Hui Qun Chinese Medicine's half -annual net profit in 2022 decreased by 5.10% year -on -year

On August 1st, Hui Qun Chinese Medicine (Code: 832513.NQ) released the performance report of the 2022 Half -Annual Report.

From January 1, 2022-June 30, 2022, the company realized operating income of 206 million yuan, an increase of 2.14%year-on-year, and net profit was 17.1435 million yuan, a year-on-year decrease of 5.10%, and the basis of basis per share was 0.3500 yuan.

The company's industry is Chinese medicine.

Among them, the pharmaceutical industry revenue was 204 million yuan, and other income was 1.8329 million yuan.

During the company's reporting period, the total assets at the end of the period were 366 million yuan, the operating profit was 18.098 million yuan, the accounts receivable were 105 million yuan, and the net cash flow generated by operating activities was 18.880 million yuan.Cash is 214 million yuan.

Huiqun Traditional Chinese Medicine, the company's full name, Guangdong Huiqun Chinese Medicine Decoction Film Co., Ltd., was established on May 10, 2007. The current general manager Lai Hong, the main business is the production and sales of traditional Chinese medicine drinks.

- END -